Judith Klimovsky's most recent trade in Bio-Techne Corp was a trade of 3,777 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 1,640 | 3,782 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 2,142 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,610 | 1,610 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 680 | 680 (0%) | 0% | 0 | Common Stock |